A SERS Biosensor Based on Functionalized Au-SiNCA Integrated with a Dual Signal Amplification Strategy for Sensitive Detection of Telomerase Activity During EMT in Laryngeal Carcinoma
DOI: https://doi.org/10.2147/IJN.S409864
IF: 7.033
2023-05-15
International Journal of Nanomedicine
Abstract:Yuexing Gu, 1, 2, &ast Yan Li, 3, &ast Shengjie Ge, 1, 2 Wenbo Lu, 4 Yu Mao, 1, 2 Miao Chen, 1, 2 Yayun Qian 1, 2 1 Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, People's Republic of China; 2 Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, People's Republic of China; 3 Department of Obstetrics and Gynecology, The Second People's Hospital of Taizhou City, Taizhou, People's Republic of China; 4 Shanxi Normal University, College of Chemistry and Material Science, Linfen, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yayun Qian, Email Purpose: This paper aims to construct a surface-enhanced Raman spectroscopy (SERS) biosensor based on functionalized Au-Si nanocone arrays (Au-SiNCA) using a dual signal amplification strategy (SDA-CHA) to evaluate telomerase activity during epithelial-mesenchymal transition (EMT) in laryngeal carcinoma (LC). Methods: A SERS biosensor based on functionalized Au-SiNCA was designed with an integrated dual-signal amplification strategy to achieve ultrasensitive detection of telomerase activity during EMT in LC patients. Results: Labeled probes (@H 1 ) and capture substrates ( 2 ) were prepared by modifying hairpin DNA and Raman signal molecules. Using this scheme, telomerase activity in peripheral mononuclear cells (PMNC) could be successfully detected with a limit of detection (LOD) as low as 10 − 6 IU/mL. In addition, biological experiments using BLM treatment of TU686 effectively mimicked the EMT process. The results of this scheme were highly consistent with the ELISA scheme, confirming its accuracy. Conclusion: This scheme provides a reproducible, selective, and ultrasensitive assay for telomerase activity, which is expected to be a potential tool for the early screening of LC in future clinical applications. Keywords: surface-enhanced Raman scattering, telomerase, laryngeal carcinoma, epithelial-mesenchymal transition, Au-SiNCA Laryngeal carcinoma (LC), the second most common head and neck malignancy worldwide, has a high incidence, significant malignancy, and poor prognosis, with a 5-year survival rate of 40%. 1,2 Surgical resection is the only possible radical treatment for LC, and patients with LC are often diagnosed with advanced stages with the development of lymph node metastases due to the lack of major-specific early clinical manifestations. 3,4 Epithelial-mesenchymal transition (EMT) is the process through which cancer cells acquire invasive mesenchymal cell-like properties, resulting in metastasis from the primary tumor site to adjacent tissues or even distal sites and ultimately leading to resistance to therapeutic intervention; thus, a systematic exploration of EMT could deepen our understanding of LC tumorigenesis and progression, which may assist in early diagnosis and effective treatment. 5,6 Telomerase is a reverse transcriptase that carries its templates and maintains telomere length by synthesizing telomeric DNA repeats, enabling the cells' unlimited proliferation. While the content of telomerase in normal cells is low due to transcriptional inhibition, researchers have proved that the mechanism of telomerase overexpression and reactivation becomes an essential factor leading to unlimited cell proliferation and malignant transformation during the EMT process of LC. 7,8 Thus, telomerase is considered an important diagnostic and prognostic cancer biomarker, and efficient determination of telomerase activity is significant. Polymerase chain reaction (PCR)-based telomere repeats amplification protocol (TRAP) is the widespread conventional method for telomerase activity detection; however, its disadvantages are also protruding, such as long detection time and false-positive results. 9–11 Although various methods, including electrochemistry, fluorescence, and colorimetric, have achieved satisfactory sensitivity and specificity, the requirement of complicated manipulation and elaborate instruments significantly limits their application in clinical research. 12,13 Benefitting from the characteristics of high-resolution, fingerprint identification, rapid analysis process, and non-destruction, surface-enhanced Raman scattering (SERS), a spectrum analysis technology bridged between Raman spectroscopy and nanotechnology, has attracted increased interest in bioanalytical applications. 14,15 In princi -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology